A second opinion before DBS surgery is medically appropriate and expected by experienced surgical teams. DBS involves permanent electrode implantation, so the decision shouldn’t rest on one assessment alone. The right questions cover candidacy, surgical experience, programming, and what happens if outcomes fall short. Clear answers going in means realistic goals and fewer surprises after.

According to Dr. Guruprasad Hosurkar, DBS surgery for Parkinson’s disease, “A second opinion doesn’t signal distrust; it confirms that a patient understands the stakes of what they’re agreeing to, and any surgical team worth their experience will welcome those questions rather than deflect them.”

Considering DBS but still unsure whether you’re the right candidate?

Candidacy and team experience aren’t separate questions. They’re connected, because the same program that assesses you also performs the procedure and manages your programming afterward.

Levodopa Response: ask what your UPDRS score improvement was on levodopa testing, because DBS outcomes correlate directly with this number and any center that hasn’t done formal on-off testing before recommending surgery is skipping a foundational step.

Case Volume: the number of DBS procedures a center performs annually matters more than most patients realize, since electrode placement accuracy and complication rates improve sharply with surgical volume and don’t plateau at low case counts.

Programming Expertise: DBS isn’t done at surgery; post-implant programming determines the actual outcome, so asking who handles programming, how many sessions are included, and what happens if adjustments don’t work is just as important as asking about the implant itself.

Neuropsychological Screening: a proper candidacy workup includes cognitive and psychiatric evaluation, and if the second opinion center hasn’t reviewed these or doesn’t ask about them, that’s a gap worth flagging before you proceed.

So the first opinion gave you a recommendation. What the second opinion should give you is confirmation of the method behind it.

Surgical candidacy sits within a broader framework of Parkinson’s disease treatment that includes medication optimization, therapy, and then surgical escalation when those aren’t enough.

Outcome questions are where most patients hold back because they don’t want to seem difficult. Ask them anyway. The answers reveal a lot about how the center communicates.

Realistic Gains: ask which specific symptoms are most likely to improve with DBS and which ones won’t respond, because tremor, rigidity, and motor fluctuations tend to improve while balance problems and cognitive symptoms often don’t, and conflating these sets up disappointment.

Complication Rates: infection, lead migration, device malfunction, and rare but serious events like bleeding or stroke carry specific percentage risks that should be stated clearly rather than described vaguely as rare or uncommon.

Medication Changes: DBS reduces medication burden in many patients but doesn’t eliminate it, and asking how much levodopa reduction is realistically expected in your case based on your current dose and response pattern gives you a concrete benchmark.

What Failure Looks Like: if DBS doesn’t deliver the expected improvement, ask what the next steps are, whether leads can be repositioned, whether programming can be escalated, and at what point the team would consider the outcome a non-response rather than a work in progress.

And honestly, a center that answers these questions with specifics rather than reassurances is probably the one doing the procedure properly.

These longer-term questions also touch on lifestyle impact, which the blog on how Parkinson’s disease affects driving and employment in India covers in detail.

Dr. Guruprasad Hosurkar holds an MBBS, MD in Internal Medicine, and DNB in Neurology, with over 22 years of experience in neurology and a focused subspecialty in movement disorders and Parkinson’s disease management. He is Director and Clinical Lead of Neurology at KIMS Hospital, Mahadevapura, and received advanced DBS training in Germany. His program was the first in India to implement adaptive closed-loop DBS. As best Parkinson’s disease doctor, he provides candidacy assessment, surgical coordination, and long-term programming under one specialist-led program.

Patients who completed a structured second opinion through his program went into surgery with documented levodopa response data, cleared neuropsychological screening, and a written programming plan, meaning no ambiguity about what the target was or how success would be measured.

References:

1. Deep Brain Stimulation for Parkinson’s Disease National Institute of Neurological Disorders and Stroke
2. DBS Outcomes and Patient Selection PubMed/NCBI